Menu
Recruiting NCT01756222

Bicuspid Aortic Valve (BAV) Registry

Observational Bicuspid Aortic Valve

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Bicuspid Aortic Valve. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry

Overview

The purpose of this registry is to gather information on patients with bicuspid aortic valve disease.

Detailed description

The purpose of this registry is to gather information on patients with bicuspid aortic valve disease. The data collected in the registry will be used to assess patterns of aortic dilation, responses to medical therapy based on serial imaging and to assess for potential genetic markers of this disease

Primary outcome measures

  • Characterizing patients with bicuspid aortic valve disease [Time frame: 30 years]

Eligibility criteria

Inclusion criteria

  • Any patient over the age of 18 who is able/willing to give informed consent with the diagnosis of bicuspid aortic valve disease, a family history of this disease or an ascending aortic aneurysm that is idiopathic can be included in the registry.

Exclusion criteria

  • Patients unable or unwilling to give informed consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • Univeristy of Michigan — Ann Arbor

Identifiers

NCT: NCT01756222 · HUM00035836

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗